144 related articles for article (PubMed ID: 1647416)
1. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice.
Tanner J; Tosato G
J Clin Invest; 1991 Jul; 88(1):239-47. PubMed ID: 1647416
[TBL] [Abstract][Full Text] [Related]
2. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
[TBL] [Abstract][Full Text] [Related]
3. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
5. High level expression of the homeobox gene HB24 in a human T-cell line confers the ability to form tumors in nude mice.
Deguchi Y; Kehrl JH
Cancer Res; 1993 Jan; 53(2):373-7. PubMed ID: 8093351
[TBL] [Abstract][Full Text] [Related]
6. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
[TBL] [Abstract][Full Text] [Related]
7. Studies of sublines selected for loss of HLA expression from an EBV-transformed lymphoblastoid cell line. Changes in sensitivity to cytotoxic T cells activated by allostimulation and natural killer cells activated by IFN or IL-2.
Ohlén C; Bejarano MT; Grönberg A; Torsteinsdottir S; Franksson L; Ljunggren HG; Klein E; Klein G; Kärre K
J Immunol; 1989 May; 142(9):3336-41. PubMed ID: 2468716
[TBL] [Abstract][Full Text] [Related]
8. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.
Tartour E; Fossiez F; Joyeux I; Galinha A; Gey A; Claret E; Sastre-Garau X; Couturier J; Mosseri V; Vives V; Banchereau J; Fridman WH; Wijdenes J; Lebecque S; Sautès-Fridman C
Cancer Res; 1999 Aug; 59(15):3698-704. PubMed ID: 10446984
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
11. The induction of IL-6 and gelatinase B by IL-1 in mouse cell lines transformed with bovine papillomavirus: decreased production in tumorigenic cells.
Fuse A; Simizu B; Van Ranst M; Opdenakker G; Van Damme J
Lymphokine Cytokine Res; 1992 Aug; 11(4):215-20. PubMed ID: 1330001
[TBL] [Abstract][Full Text] [Related]
12. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer.
Suzuki K; Nakazato H; Matsui H; Hasumi M; Shibata Y; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
J Leukoc Biol; 2001 Apr; 69(4):531-7. PubMed ID: 11310838
[TBL] [Abstract][Full Text] [Related]
13. Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene.
Corrias MV; Basso S; Meazza R; Musiani P; Santi L; Bocca P; Occhino M; Ferrini S; Pistoia V
Cancer Gene Ther; 1998; 5(1):38-44. PubMed ID: 9476965
[TBL] [Abstract][Full Text] [Related]
14. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
Freund GG; Kulas DT; Way BA; Mooney RA
Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
[TBL] [Abstract][Full Text] [Related]
15. Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice.
Durandy A; Emilie D; Peuchmaur M; Forveille M; Clement C; Wijdenes J; Fischer A
J Immunol; 1994 Jun; 152(11):5361-7. PubMed ID: 8189054
[TBL] [Abstract][Full Text] [Related]
16. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
17. Re-expression of interleukin 1 in human papillomavirus 18 immortalized keratinocytes inhibits their tumorigenicity in nude mice.
Merrick DT; Winberg G; McDougall JK
Cell Growth Differ; 1996 Dec; 7(12):1661-9. PubMed ID: 8959334
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
[TBL] [Abstract][Full Text] [Related]
20. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
